Hepatitis B Virus Antibody Booster Program for the Production of Hepatitis B Immune Globulin (HBIG)

Clinical trial NCT01311674 · TERMINATED

Trial details

NCT number: NCT01311674
Sponsor: Emergent BioSolutions
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2009-09-01
Primary completion: 2011-03-11
Enrollment: 141

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.